zeneca zd 6169 has been researched along with nefazodone in 1 studies
| Studies (zeneca zd 6169) | Trials (zeneca zd 6169) | Recent Studies (post-2010) (zeneca zd 6169) | Studies (nefazodone) | Trials (nefazodone) | Recent Studies (post-2010) (nefazodone) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 532 | 154 | 48 |
| Protein | Taxonomy | zeneca zd 6169 (IC50) | nefazodone (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 6.735 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 4.7 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.037 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for zeneca zd 6169 and nefazodone
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |